The Journal of Immunology, Vol 156, Issue 11 4298-4308, Copyright © 1996 by American Association of Immunologists

ARTICLES

Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells

L Gorelik, Y Bar-Dagan and MB Mokyr
Department of Biochemistry, University of Illinois at Chicago, IL 60680, USA.

We have shown previously that addition of TNF to stimulation cultures of MOPC-315 tumor bearer splenic cell suspensions containing metastatic tumor cells capable of secreting TGF-beta greatly enhances the generation of anti-MOPC-315 lytic activity by their CD8+ T cells. The current studies were undertaken to gain some insight into the mechanism(s) through which TNF potentiates the in vitro generation of anti-MOPC-315 cytotoxicity by such tumor bearer splenic cells. Here we show that TNF is capable of 1) preventing completely the inhibitory activity of TGF-beta for CTL generation when both cytokines are added at the time of initiation of a 5-day stimulation culture and 2) reversing at least part of the inhibitory activity of TGF-beta when TNF is added as late as 3 days after TGF-beta addition. The costimulatory molecule B7-2 is shown here to be important for the realization of the potentiating activity of TNF for CTL generation by tumor bearer splenic cells. However, despite the importance of the B7-2 molecule, TNF does not mediate its immunopotentiating activity for CTL generation through up-regulation in IL-2 production. In addition, we show here that GM- CSF, but not IL-12, is important for the potentiating effect of TNF for CTL generation by tumor bearer splenic cells. Taken together, these studies identify several factors that are important for the realization of the potentiating effect of TNF for the in vitro generation of antitumor cytotoxicity by tumor-infiltrated splenic cells. It is not known at present, however, whether these factors utilize distinct and/or overlapping mechanisms in realizing the TNF effect.

This article has been cited by other articles:

				D. W. Mullins, R. S. Martins, and K. D. Elgert Tumor-Derived Cytokines Dysregulate Macrophage Interferon-{gamma} Responsiveness and Interferon Regulatory Factor-8 Expression Experimental Biology and Medicine, March 1, 2003; 228(3): 270 - 277. [Abstract] [Full Text] [PDF]

				V. M. Jovasevic and M. B. Mokyr Melphalan-Induced Expression of IFN-{beta} in MOPC-315 Tumor-Bearing Mice and Its Importance for the Up-Regulation of TNF-{alpha} Expression J. Immunol., November 1, 2001; 167(9): 4895 - 4901. [Abstract] [Full Text] [PDF]

				R. M. Kedl, M. Jordan, T. Potter, J. Kappler, P. Marrack, and S. Dow CD40 stimulation accelerates deletion of tumor-specific CD8+ T cells in the absence of tumor-antigen vaccination PNAS, August 23, 2001; (2001) 191371898. [Abstract] [Full Text] [PDF]

				M. Donepudi, P. Raychaudhuri, J. A. Bluestone, and M. B. Mokyr Mechanism of Melphalan-Induced B7-1 Gene Expression in P815 Tumor Cells J. Immunol., June 1, 2001; 166(11): 6491 - 6499. [Abstract] [Full Text] [PDF]

				B. W. Anderson, G. E. Peoples, J. L. Murray, M. A. Gillogly, D. M. Gershenson, and C. G. Ioannides Peptide Priming of Cytolytic Activity to HER-2 Epitope 369-377 in Healthy Individuals Clin. Cancer Res., November 1, 2000; 6(11): 4192 - 4200. [Abstract] [Full Text] [PDF]

				J. L. Prehn, C. J. Landers, and S. R. Targan A Soluble Factor Produced by Lamina Propria Mononuclear Cells Is Required for TNF-{alpha} Enhancement of IFN-{gamma} Production by T Cells J. Immunol., October 15, 1999; 163(8): 4277 - 4283. [Abstract] [Full Text] [PDF]

				V. V. Kalinichenko, M. B. Mokyr, L. H. Graf Jr., R. L. Cohen, and D. A. Chambers Norepinephrine-Mediated Inhibition of Antitumor Cytotoxic T Lymphocyte Generation Involves a {beta}-Adrenergic Receptor Mechanism and Decreased TNF-{alpha} Gene Expression J. Immunol., September 1, 1999; 163(5): 2492 - 2499. [Abstract] [Full Text] [PDF]

				M. B. Mokyr, T. V. Kalinichenko, L. Gorelik, and J. A. Bluestone Importance of the B7-2 Molecule for Low Dose Melphalan-Induced Acquisition of Tumor-Eradicating Immunity by Mice Bearing a Large MOPC-315 Tumor J. Immunol., February 15, 1998; 160(4): 1866 - 1874. [Abstract] [Full Text] [PDF]

				R. M. Kedl, M. Jordan, T. Potter, J. Kappler, P. Marrack, and S. Dow CD40 stimulation accelerates deletion of tumor-specific CD8+ T cells in the absence of tumor-antigen vaccination PNAS, September 11, 2001; 98(19): 10811 - 10816. [Abstract] [Full Text] [PDF]